Tiger Aesthetics

At Tiger Aesthetics, we are committed to delivering new, cutting-edge products that meet the evolving needs of aesthetic practitioners and their patients. With a focus on three primary clinical areas – reconstruction, cosmetic and regenerative – Tiger Aesthetics enables practitioners to provide life-changing results for a wide range of patients. Our innovative technologies and products represent a unique opportunity to advance the field of Aesthetic Medicine. In 2024, Tiger Aesthetics completed the strategic acquisition of three aesthetic portfolios. The Sientra® product portfolio, including HSC/HSC+ gel breast implants, AlloX2® and DermaspanTM tissue expanders and the VialityTM fat transfer system, the Suneva® product portfolio with Bellafill® biostimulatory filler, Silhouette Instalift® non-surgical facelift threads and the Amplfine PRP platform, and Revelle Aesthetics’ Avéli® cellulite treatment device. These acquisitions complement Tiger Aesthetics’ adipose cell and tissue products, alloClae and dermaClae, to provide a head-to-toe range of new treatment options for plastic surgeons, dermatologists and their patients. Tiger Aesthetics, built for the future of aesthetics.